Pharmacovigilance

Pharmacovigilance (PV) is defined by the World Health Organization (WHO) as science and activities related to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problems. It plays a key role in ensuring that appropriate patients receive medical products that are safe in the context of the benefits these products provide. The Pharmacovigilance PWA promotes convergent evolution of pharmacovigilance (PV) activities among APEC economies that will support harmonized and pragmatic regulatory requirements in Pharmacovigilance by 2020.

CHAMPION

  • Ministry of Food and Drug Safety (MFDS), Korea

CENTERS OF EXCELLENCE

  • Peking University (PKU), China 
  • Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Korea Institute of Drug Safety and Risk Management (KIDS), Korea

ACTIVITIES

2020

SEP

APEC CoE Training (Online)

Korea Institute of Drug Safety and Risk Management (KIDS), Korea

SEP

APEC CoE Training (Online)

Peking University (PKU), China

FEB

APEC CoE Training (Japan)

Pharmaceutical and Medical Devices Agency (PMDA), Japan

2019

SEP

APEC CoE Training (Korea)

Korea Institute of Drug Safety and Risk Management (KIDS), Korea

AUG

APEC Center of Excellence established

Peking University (PKU), China

APR

APEC Pilot CoE Training (China)

Peking University (PKU), China

FEB

APEC CoE Training (Japan)

Pharmaceutical and Medical Devices Agency (PMDA), Japan

2018

SEP

APEC CoE Training (Korea)

Korea Institute of Drug Safety and Risk Management (KIDS), Korea

AUG

APEC Pilot Center of Excellence established

Peking University (PKU), China

FEB

APEC CoE Training (Japan)

Pharmaceutical and Medical Devices Agency (PMDA), Japan

2017

SEP

APEC CoE Training (Korea)

Korea Institute of Drug Safety and Risk Management (KIDS), Korea

PWA Champion MFDS Workshop (Korea)

AUG

APEC Center of Excellence established

Korea Institute of Drug Safety and Risk Management (KIDS), Korea

FEB

APEC Center of Excellence established

Pharmaceutical and Medical Devices Agency (PMDA), Japan

APEC Pilot CoE Training (Japan)

Pharmaceutical and Medical Devices Agency (PMDA), Japan

2016

SEP

APEC Pilot CoE Training (Korea)

Korea Institute of Drug Safety and Risk Management (KIDS), Korea

2015

SEP

APEC Pilot CoE Training (Korea)

Korea Institute of Drug Safety and Risk Management (KIDS), Korea